A detailed history of Bedel Financial Consulting, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 13,905 shares of JNJ stock, worth $2.13 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
13,905
Previous 14,153 1.75%
Holding current value
$2.13 Million
Previous $2.07 Million 8.95%
% of portfolio
0.31%
Previous 0.3%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $36,079 - $41,510
-248 Reduced 1.75%
13,905 $2.25 Million
Q2 2024

Aug 05, 2024

SELL
$144.38 - $157.78 $46,634 - $50,962
-323 Reduced 2.23%
14,153 $2.07 Million
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $2,173 - $2,278
14 Added 0.1%
14,476 $2.29 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $70,470 - $76,897
-484 Reduced 3.24%
14,462 $2.27 Million
Q3 2023

Feb 08, 2024

BUY
$155.75 - $174.48 $11,369 - $12,737
73 Added 0.49%
14,946 $2.33 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $8,026 - $8,637
52 Added 0.35%
14,873 $2.46 Million
Q1 2023

May 02, 2023

BUY
$151.05 - $180.26 $33,079 - $39,476
219 Added 1.5%
14,821 $2.3 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $35,724 - $40,093
223 Added 1.55%
14,602 $2.58 Million
Q3 2022

Nov 08, 2022

BUY
$161.33 - $179.52 $4,355 - $4,847
27 Added 0.19%
14,379 $2.49 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $119,078 - $131,695
708 Added 5.19%
14,352 $2.55 Million
Q1 2022

Apr 19, 2022

BUY
$158.14 - $179.59 $29,888 - $33,942
189 Added 1.4%
13,644 $2.42 Million
Q4 2021

Jan 11, 2022

SELL
$155.93 - $173.01 $218,925 - $242,906
-1,404 Reduced 9.45%
13,455 $2.3 Million
Q3 2021

Oct 12, 2021

BUY
$161.5 - $179.47 $6,137 - $6,819
38 Added 0.26%
14,859 $2.4 Million
Q2 2021

Aug 03, 2021

BUY
$159.48 - $171.07 $81,175 - $87,074
509 Added 3.56%
14,821 $2.44 Million
Q1 2021

Apr 26, 2021

BUY
$153.07 - $170.48 $548,602 - $611,000
3,584 Added 33.41%
14,312 $2.35 Million
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $274 - $314
2 Added 0.02%
10,728 $1.69 Million
Q3 2020

Oct 20, 2020

SELL
$140.38 - $153.83 $3,228 - $3,538
-23 Reduced 0.21%
10,726 $1.6 Million
Q2 2020

Jul 14, 2020

SELL
$128.81 - $155.51 $105,624 - $127,518
-820 Reduced 7.09%
10,749 $1.51 Million
Q1 2020

May 06, 2020

SELL
$111.14 - $153.99 $83,577 - $115,800
-752 Reduced 6.1%
11,569 $1.52 Million
Q4 2019

Jan 28, 2020

SELL
$127.5 - $146.44 $1,530 - $1,757
-12 Reduced 0.1%
12,321 $1.8 Million
Q3 2019

Oct 09, 2019

SELL
$126.95 - $142.14 $18,153 - $20,326
-143 Reduced 1.15%
12,333 $1.6 Million
Q2 2019

Aug 01, 2019

SELL
$131.15 - $144.24 $19,410 - $21,347
-148 Reduced 1.17%
12,476 $1.74 Million
Q1 2019

May 02, 2019

BUY
$125.72 - $139.79 $251 - $279
2 Added 0.02%
12,624 $1.77 Million
Q4 2018

Jan 28, 2019

SELL
$122.84 - $147.84 $69,158 - $83,233
-563 Reduced 4.27%
12,622 $1.63 Million
Q3 2018

Nov 01, 2018

BUY
$121.58 - $142.88 $7,537 - $8,858
62 Added 0.47%
13,185 $1.8 Million
Q2 2018

Jul 18, 2018

BUY
$119.4 - $131.76 $142,563 - $157,321
1,194 Added 10.01%
13,123 $1.59 Million
Q1 2018

May 03, 2018

BUY
$125.1 - $148.14 $15,762 - $18,665
126 Added 1.07%
11,929 $1.53 Million
Q4 2017

Feb 06, 2018

BUY
$131.22 - $143.62 $1.55 Million - $1.7 Million
11,803
11,803 $1.65 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bedel Financial Consulting, Inc. Portfolio

Follow Bedel Financial Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.